Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity

FEI registration will enable release-testing of pharmaceutical raw materials and finished products for the US market.
FEI registration allows customers to name Concept Life Sciences as test facility for other regulatory submissions, such as IND.
10-fold expansion of Concept’s ICH stability storage accommodates bulkier finished products and builds on its existing full-service offering across all ICH conditions.

Read More

Thoughts from our expert: David Higton Principal Scientist Biotransformation

It was interesting to hear this week of the FDA refusal to review a recent NDA application due to a lack of data on metabolism and metabolite activity. http://blogs.sciencemag.org/pipeline/archives/2018/06/14/finger-pointing-at-celgene
In recent years it has become routine to perform comprehensive biotransformation studies early in drug development to ensure that issues such as this are known and are addressed.

Read More

World Malaria Day 2018 (#worldmalariaday)

 
Nearly half of the world’s population is at risk of malaria. In 2015, there were roughly 212 million malaria cases and an estimated 429 000 malaria deaths. Increased prevention and control measures have led to a 29% reduction in malaria mortality rates globally since 2010.*
Our infographic below highlights “Antimalarial Therapy Throughout the Ages”

Read More

Concept Life Sciences appoints Matilda Bingham as Site Director and David Higton as Biotransformation and Metabolite Identification Expert, at its Alderley Park site

Appointments support expansion of expertise in integrated drug discovery and development
Manchester, UK, 24 April 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Matilda Bingham as Site Director of its Alderley Park site in Cheshire,

Read More

Gender Pay Gap Report April 2017

Legislation introduced in April 2017 requires all legal entities of 250 or more employees to publish their gender pay gap. The gender pay gap is the difference between the average earnings of men and women, expressed relative to men’s earnings.  For example,

Read More

Concept Life Sciences Head Of Bioassay and Development Dr Andrew Scott Publishes a chapter entitled “Fluorescent Thermal Shift Assays For Identifying Small Molecule Ligands

At Concept Life Sciences we are proud to offer extensive biophysical assay expertise which complements our existing capabilities in pharmaceutical discovery and development.
As a result of our ongoing work and extensive research, we are pleased to announce that our Head of Bioassay Development and Screening,

Read More

Concept Life Sciences expands GXP compliance

Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis
GLP ensures quality and integrity in non-clinical laboratory studies and gives confidence in safety assessment

 Manchester and Dundee, UK, 8th February 2018: Concept Life Sciences (“Concept”),

Read More

CONCEPT LIFE SCIENCES TO SPEAK AT INAUGURAL NORTH OF ENGLAND CANCER CONFERENCE

Ahead of #WorldCancerDay on Sunday 4th February, we are delighted announce our support to the Alderley Park and Bionow event ‘Accelerating Cancer Drug Development – From Target to Patients’.
Taking Place on 27th February at Alderley Park Conference Centre, our Group Leader Thomas Pesnot will be giving a talk titled ‘Tailoring Screening Libraries for Neuro-Oncology using Multiparameter Optimisation’.

Read More

Concept Life Sciences Group acquired by Spectris plc

Acquisition increases Concept’s global reach and supports growth strategy
Synergies with Spectris’ molecular testing and analysis expertise will provide customers with
access to a broader range of services

Manchester and Egham, UK, 26 January 2018: Concept Life Sciences (‘Concept’),

Read More

Aquila BioMedical secures Macrophage Pharma agreement

09 November 2017: Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma Ltd. to support its preclinical immuno-oncology programmes.
Macrophage Pharma’s Esterase Sensitive Motif™

Read More

Concept Life Sciences announces acquisition of Aquila BioMedical

Acquisition adds immuno-oncology capability to broaden Concept’s range of integrated drug discovery and development services
Manchester, UK, 30 October 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has acquired Aquila BioMedical (Aquila),

Read More

WIN at CPhI Worldwide

Concept Life Sciences are attending the upcoming CPhI Worldwide event, taking place in Frankfurt, Germany between October 24th – 26th. We will be running a competition to win an Apple Watch.
HOW TO ENTER:

Attend CPhI Worldwide
Arrange a meeting with a Concept Life Sciences representative (Will Bromley, 

Read More

Win an Apple Watch at ACS Chemistry for Life

If you are attending ACS Chemistry for Life then you could be in with a chance of winning an Apple Watch.
To enter the Competition you must be attending the event (ACS) and schedule a meeting with our Director of Business Development for North America Heidi Schulze.

Read More

Concept Life Sciences Announces the Appointment of John Handley as Chief Operating Officer as the Company Prepares for the Next Stage of Growth and Development

Concept Life Sciences a knowledge-based, science-led business providing a wide range of innovative and integrated solutions within the pharmaceutical, biotechnology, food, environmental, agrochemical, biocides, chemical and consumer sectors, today announces the appointment of John Handley as Chief Operating Officer.
In his role,

Read More

Fipronil Testing in Contaminated Eggs

Fipronil is an insecticide commonly used in veterinary products to treat fleas, mites and marks.  However, it is banned from the use in animals that will enter the food chain such as chickens.
Recent unauthorised use of products containing Fipronil has led to its residues to be found in eggs that have entered the food chain in mainland Europe and in small numbers of eggs entering the UK market.

Read More

Analytical Services Division Careers Open Day – Cambridge

Interested in Developing a Career in Analytical Sciences? Meet the Science behind the Concept at our Analytical Services Division Careers Open Day
Following on from the success of our first careers open day, Concept Life Sciences Analytical Services Division host another open day on Thursday 21st September.

Read More

Concept Life Sciences strengthens Assay Development and Screening Expertise with the appointment of Dr Andrew CLifton

Dr Andrew Clifton joins Concept Life Sciences as Head of Bioassay Development and Screening Technologies. Concept Life Sciences offers tailored preclinical services including integrated drug discovery programs. Dr Clifton strengthens the existing industry team at Concept and will be responsible for providing assay development and screening capabilities to support preclinical drug discovery projects from hit finding through to candidate selection.

Read More

COMPETITION TIME!

To celebrate the launch of our new website, we are pleased to announce our exciting summer competition!
For your chance to win a £100 Amazon Gift Card*, all you have to do is subscribe to the Concept Life Sciences newsletter by 12pm,

Read More

Analytical Services Careers Open Day

Interested in Developing a Career in Analytical Sciences? Meet the Science behind the Concept at our Analytical Services Division Careers Open Day
Concept Life Sciences Analytical Services Division are hosting an open day on Tuesday 18th July. Taking place at our Manchester site the open day aims to give you the opportunity to meet the team,

Read More

Concept Life Sciences further expands its service offering by investing in micro chamber and thermal extraction facilities

Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro-Chamber and Thermal Extraction facilities , used to sample VOCs or SVOCs emitted from products and materials. The investment has been made to cope with the growing demand from both new and existing clients who insist on speedy,

Read More

Concept Life Sciences launches REACH testing services

Concept Life Sciences, the group created from the merger of Scientific Analysis Laboratories, Agenda1, Peakdale Molecular, CXR Biosciences and REC, has launched two REACH testing services.
The first testing service is Substance Sameness and Identification Testing for the 2018 REACH Registration deadline.

Read More

Analytical Services Training Courses

Concept Life Sciences – Analytical Services are hosting several training courses across the UK. Continuing on from the success of 2016, course dates have now been booked for the Microbiology and Pesticides training courses in Cambridge.

INTRODUCTION TO MICROBIOLOGY TESTING IN FOOD
CAMBRIDGE
Price includes refreshments,

Read More

Concept Life Sciences (Formerly CXR Biosciences) Co-Authors Two Posters Describing Mode of Action Studies at the Society of Toxicology 2017 Annual Meeting

Research carried out at Concept Life Sciences (formerly CXR Biosciences), the investigative & exploratory toxicology company, is being presented in two posters at the upcoming Society Of Toxicology (SOT) 2017 annual meeting in Baltimore on 12th – 16th March.  This mechanistic research has been performed in partnership with Endura SpA,

Read More

Is 2017 the year to expand upon your capabilities?

Scientific Analysis Laboratories (SAL) are starting the year off by hosting several training courses across the UK. Continuing on from the success of 2016, course dates have now been booked for the Microbiology and Pesticides training courses in Cambridge – with a new,

Read More